US6861571B1
(en)
*
|
1994-11-28 |
2005-03-01 |
The Procter & Gamble Company |
Article having a lotioned topsheet
|
JPH10510540A
(ja)
|
1994-12-12 |
1998-10-13 |
オメロス メディカル システムズ,インコーポレーテッド |
灌注用溶液並びに疼痛、炎症及びけいれんの抑制法
|
US6413961B1
(en)
|
1995-12-12 |
2002-07-02 |
Omeros Medical Systems, Inc. |
Irrigation solution and method for inhibition of pain and inflammation
|
AUPN814496A0
(en)
*
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
US6929801B2
(en)
*
|
1996-02-19 |
2005-08-16 |
Acrux Dds Pty Ltd |
Transdermal delivery of antiparkinson agents
|
US6916487B2
(en)
*
|
1996-02-19 |
2005-07-12 |
Acrux Dds Pty Ltd |
Transdermal delivery of antiemetics
|
US7094422B2
(en)
*
|
1996-02-19 |
2006-08-22 |
Acrux Dds Pty Ltd. |
Topical delivery of antifungal agents
|
US6916486B2
(en)
*
|
1996-02-19 |
2005-07-12 |
Acrux Dds Pty Ltd |
Transdermal delivery of analgesics
|
US6923983B2
(en)
*
|
1996-02-19 |
2005-08-02 |
Acrux Dds Pty Ltd |
Transdermal delivery of hormones
|
US6512010B1
(en)
*
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
US8022095B2
(en)
*
|
1996-08-16 |
2011-09-20 |
Pozen, Inc. |
Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
|
GR1002847B
(el)
|
1997-05-06 |
1998-01-27 |
|
Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως
|
US6767902B2
(en)
*
|
1997-09-17 |
2004-07-27 |
The Population Council, Inc. |
Androgen as a male contraceptive and non-contraceptive androgen replacement
|
US20050287075A1
(en)
*
|
1997-10-01 |
2005-12-29 |
Dugger Harry A Iii |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
US20050163719A1
(en)
*
|
1997-10-01 |
2005-07-28 |
Dugger Harry A.Iii |
Buccal, polar and non-polar spray containing diazepam
|
US20030185761A1
(en)
|
1997-10-01 |
2003-10-02 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
US20050180923A1
(en)
*
|
1997-10-01 |
2005-08-18 |
Dugger Harry A.Iii |
Buccal, polar and non-polar spray containing testosterone
|
US20030077229A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
|
US20040136913A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing sumatriptan
|
US7632517B2
(en)
*
|
1997-10-01 |
2009-12-15 |
Novadel Pharma Inc. |
Buccal, polar and non-polar spray containing zolpidem
|
US20040136915A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing atropine
|
US20090162300A1
(en)
*
|
1997-10-01 |
2009-06-25 |
Dugger Iii Harry A |
Buccal, polar and non-polar spray containing alprazolam
|
US20040136914A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing ondansetron
|
US20030077228A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
|
WO1999016417A1
(en)
*
|
1997-10-01 |
1999-04-08 |
Flemington Pharmaceutical Corporation |
Buccal, polar and non-polar spray or capsule
|
US20050281752A1
(en)
*
|
1997-10-01 |
2005-12-22 |
Dugger Harry A Iii |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
US20040141923A1
(en)
*
|
1997-10-01 |
2004-07-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing alprazolam
|
US20030095927A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
|
US20030190286A1
(en)
*
|
1997-10-01 |
2003-10-09 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
|
US20030095925A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
|
US20050002867A1
(en)
*
|
1997-10-01 |
2005-01-06 |
Novadel Pharma Inc. |
Buccal, polar and non-polar sprays containing propofol
|
US20030077227A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
US20030082107A1
(en)
*
|
1997-10-01 |
2003-05-01 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
|
US20030095926A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
|
US5968919A
(en)
*
|
1997-10-16 |
1999-10-19 |
Macrochem Corporation |
Hormone replacement therapy drug formulations for topical application to the skin
|
US7098206B2
(en)
|
1998-01-21 |
2006-08-29 |
Smithkline Beecham Corporation |
Pharmaceutically active morpholinol
|
US6998400B2
(en)
|
1998-01-22 |
2006-02-14 |
Smithkline Beecham Corporation |
Pharmaceutically active morpholinol
|
EP1051167A1
(de)
*
|
1998-01-29 |
2000-11-15 |
Sepracor, Inc. |
Pharmazeutische verwendungen von optisch reinem (-)- bupropion
|
EP1051163A2
(de)
*
|
1998-01-29 |
2000-11-15 |
Sepracor, Inc. |
Methoden und zusammenstellungen zur hilfe beim einstellen des rauchens und zur behandlung von schmerzen und anderen krankheiten durch verwendung von optisch reinem (-)-bupropion
|
CA2318921A1
(en)
|
1998-01-29 |
1999-08-05 |
John R. Mccullough |
Pharmacological uses of optically pure (+)-bupropion
|
DE19814084B4
(de)
|
1998-03-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
|
IL124764A0
(en)
*
|
1998-06-04 |
1999-01-26 |
Univ Ben Gurion |
Topical composition for treatment of baldness
|
DE19825591A1
(de)
*
|
1998-06-09 |
1999-12-23 |
Jenapharm Gmbh |
Pharmazeutische Kombinationen zum Ausgleich eines Testosteron-Defizits beim Mann mit gleichzeitigem Schutz der Prostata
|
GR1003199B
(el)
|
1998-08-14 |
1999-09-01 |
|
Χρηση της μισοπροστολης ή και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση της σεξουαλικης δυσλειτουργιας στις γυναικες
|
DE69933775T2
(de)
|
1998-08-20 |
2007-10-04 |
3M Innovative Properties Co., St. Paul |
Sprühverband und wirkstoffabgabesystem
|
NZ512716A
(en)
*
|
1998-12-08 |
2003-10-31 |
Planisphere Corp |
Use of bupropion to treat viral diseases
|
GB9828480D0
(en)
*
|
1998-12-24 |
1999-02-17 |
Dermatech Limited |
Transdermal drug delivery system
|
NZ512676A
(en)
|
1999-01-13 |
2003-01-31 |
Meditech Res Ltd |
A composition and method for the enhancement of the efficacy of drugs
|
US6855820B2
(en)
|
1999-01-20 |
2005-02-15 |
Smithkline Beecham Corporation |
Pharmaceutically active morpholinol
|
US6734213B2
(en)
|
1999-01-20 |
2004-05-11 |
Smithkline Beecham Corporation |
Pharmaceutically active morpholinol
|
KR100390870B1
(ko)
*
|
1999-02-09 |
2003-07-10 |
주식회사 삼양사 |
경피투여용 항구토제 조성물 및 이를 포함하는 제제
|
US6337328B1
(en)
|
1999-03-01 |
2002-01-08 |
Sepracor, Inc. |
Bupropion metabolites and methods of use
|
US6342496B1
(en)
|
1999-03-01 |
2002-01-29 |
Sepracor Inc. |
Bupropion metabolites and methods of use
|
KR20010108316A
(ko)
|
1999-03-05 |
2001-12-07 |
데이비드 엠 모이어 |
C16 불포화된 fp-선택적 프로스타글란딘 유사체
|
DE19918105C1
(de)
|
1999-04-22 |
2000-09-21 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit einem stark wirksamen Neuroleptikum
|
US6428769B1
(en)
*
|
1999-05-04 |
2002-08-06 |
Aradigm Corporation |
Acute testosterone administration
|
US6632419B2
(en)
|
1999-05-04 |
2003-10-14 |
Aradigm Corporation |
Increasing libido in humans via acute testosterone administration
|
EP1175204A4
(de)
*
|
1999-05-04 |
2006-05-31 |
Aradigm Corp |
Aerosolformulierung und artikel zur steigerung der libido bei frauen durch momentane testosteronverabreichung
|
US7258850B2
(en)
|
1999-05-04 |
2007-08-21 |
Aradigm Corporation |
Methods and compositions for treating erectile dysfunction
|
US6312716B1
(en)
*
|
1999-05-10 |
2001-11-06 |
Peierce Management Llc |
Patch and method for transdermal delivery of bupropion base
|
US6280763B1
(en)
|
1999-05-10 |
2001-08-28 |
Pierce Management, Llc |
Apparatus and method for transdermal delivery of bupropion
|
US20020172693A1
(en)
|
2000-03-31 |
2002-11-21 |
Delong Michell Anthony |
Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
|
US20020013294A1
(en)
|
2000-03-31 |
2002-01-31 |
Delong Mitchell Anthony |
Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
|
US6595947B1
(en)
*
|
2000-05-22 |
2003-07-22 |
Becton, Dickinson And Company |
Topical delivery of vaccines
|
US7241731B2
(en)
|
2000-06-05 |
2007-07-10 |
Sumitomo Electric Industries, Ltd. |
Oligopeptides for promoting hair growth
|
US20050008602A1
(en)
*
|
2000-06-05 |
2005-01-13 |
Sumitomo Electric Industries, Ltd. |
Oligopeptides for promoting hair growth
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
US9066919B2
(en)
*
|
2000-07-14 |
2015-06-30 |
Alchemia Oncology Pty Limited |
Hyaluronan as a chemo-sensitizer in the treatment of cancer
|
AUPQ879500A0
(en)
*
|
2000-07-14 |
2000-08-10 |
Meditech Research Limited |
Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
US7214381B2
(en)
|
2000-08-03 |
2007-05-08 |
Antares Pharma Ipl Ag |
Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
US7198801B2
(en)
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
DE10041479A1
(de)
*
|
2000-08-24 |
2002-03-14 |
Sanol Arznei Schwarz Gmbh |
Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
|
DE10041478A1
(de)
*
|
2000-08-24 |
2002-03-14 |
Sanol Arznei Schwarz Gmbh |
Neue pharmazeutische Zusammensetzung
|
DE10066158B4
(de)
*
|
2000-08-24 |
2007-08-09 |
Neurobiotec Gmbh |
Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
|
DE10053397A1
(de)
|
2000-10-20 |
2002-05-02 |
Schering Ag |
Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
DE10042411A1
(de)
*
|
2000-08-30 |
2002-03-28 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System zur Abgabe von Exemestan
|
EP2283865A1
(de)
*
|
2000-08-30 |
2011-02-16 |
Unimed Pharmaceuticals, LLC |
Verfahren zur Erhöhung des Testosteron-Spiegels und verwandter Steroidverbindungen bei Frauen
|
AU8986501A
(en)
*
|
2000-09-08 |
2002-03-22 |
Pharmacia & Upjohn Spa |
Exemestane as chemopreventing agent
|
DE10064453A1
(de)
*
|
2000-12-16 |
2002-07-04 |
Schering Ag |
Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
|
US20020177626A1
(en)
|
2001-01-19 |
2002-11-28 |
Cook Graham D. |
Treatment of sleep disturbances
|
FR2815256A1
(fr)
*
|
2001-01-23 |
2002-04-19 |
Oreal |
Composition, notamment cosmetique, comprenant au moins un derive de sapogenine et au moins un solubilisant du derive de sapogenine
|
JP3767392B2
(ja)
*
|
2001-02-05 |
2006-04-19 |
日産自動車株式会社 |
エンジンのカム軸回転位相検出装置及びシリンダ吸入空気量算出装置
|
US20020172732A1
(en)
*
|
2001-03-21 |
2002-11-21 |
Wies Ter Laak |
Composition comprising cocoa
|
US20030027793A1
(en)
*
|
2001-05-08 |
2003-02-06 |
Thomas Lauterback |
Transdermal treatment of parkinson's disease
|
US20030026830A1
(en)
*
|
2001-05-08 |
2003-02-06 |
Thomas Lauterback |
Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
|
US7498019B2
(en)
|
2001-05-24 |
2009-03-03 |
Alexza Pharmaceuticals, Inc. |
Delivery of compounds for the treatment of headache through an inhalation route
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
US7458374B2
(en)
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
US20030051728A1
(en)
|
2001-06-05 |
2003-03-20 |
Lloyd Peter M. |
Method and device for delivering a physiologically active compound
|
US6737042B2
(en)
|
2001-05-24 |
2004-05-18 |
Alexza Molecular Delivery Corporation |
Delivery of drug esters through an inhalation route
|
US7645442B2
(en)
|
2001-05-24 |
2010-01-12 |
Alexza Pharmaceuticals, Inc. |
Rapid-heating drug delivery article and method of use
|
US7244703B2
(en)
|
2001-06-22 |
2007-07-17 |
Bentley Pharmaceuticals, Inc. |
Pharmaceutical compositions and methods for peptide treatment
|
WO2003000158A1
(en)
*
|
2001-06-22 |
2003-01-03 |
Bentley Pharmaceuticals, Inc. |
Pharmaceutical composition
|
WO2003018023A1
(en)
*
|
2001-08-23 |
2003-03-06 |
Bruce Frome |
Compositions and methods for targeting cerebral circulation and treatment of headache
|
US20040138239A1
(en)
*
|
2001-08-23 |
2004-07-15 |
Bruce Frome |
Compositions and methods for targeting cerebral circulation and treatment of headache
|
DE10141650C1
(de)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
CN1578677A
(zh)
*
|
2001-08-27 |
2005-02-09 |
美迪泰克研究有限公司 |
改良的治疗方案
|
US6723077B2
(en)
*
|
2001-09-28 |
2004-04-20 |
Hewlett-Packard Development Company, L.P. |
Cutaneous administration system
|
WO2003051284A2
(en)
*
|
2001-10-29 |
2003-06-26 |
Becton, Dickinson And Company |
Method and device for the delivery of a substance
|
US20040120964A1
(en)
*
|
2001-10-29 |
2004-06-24 |
Mikszta John A. |
Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses
|
US7037513B1
(en)
|
2005-01-31 |
2006-05-02 |
Aquea Scientific Corporation |
Bodywash additives
|
US6998113B1
(en)
|
2005-01-31 |
2006-02-14 |
Aquea Scientific Corporation |
Bodywashes containing additives
|
US7025952B1
(en)
|
2005-01-31 |
2006-04-11 |
Aquea Scientific Corporation |
Methods of preparation and use of bodywashes containing additives
|
US20060173709A1
(en)
*
|
2005-01-31 |
2006-08-03 |
Traynor Daniel H |
Bodywash additive business methods
|
CA2471400A1
(en)
|
2001-12-20 |
2003-07-03 |
Femmepharma, Inc. |
Vaginal delivery of drugs
|
US20040097871A1
(en)
*
|
2002-01-03 |
2004-05-20 |
Israel Yerushalmy |
Apparatus for treating sleep disorders
|
US20030143165A1
(en)
*
|
2002-01-25 |
2003-07-31 |
Allan Evans |
NSAID-containing topical formulations that demonstrate chemopreventive activity
|
US20030161802A1
(en)
*
|
2002-02-05 |
2003-08-28 |
Flammer Linda J. |
Anti-dandruff and anti-itch compositions containing sensate and sensate enhancer-containing compounds
|
AUPS317102A0
(en)
*
|
2002-06-25 |
2002-07-18 |
Drug Delivery Solutions Pty Ltd |
Transdermal aerosol compositions
|
AUPS317302A0
(en)
*
|
2002-06-25 |
2002-07-18 |
Drug Delivery Solutions Pty Ltd |
Metastable pharmaceutical compositions
|
AU2003240300A1
(en)
*
|
2002-06-25 |
2004-01-06 |
Cosmeceutic Solutions Pty Ltd |
Topical cosmetic compositions
|
AU2003238543B2
(en)
*
|
2002-06-25 |
2008-02-28 |
Acrux Dds Pty Ltd |
Transdermal aerosol compositions
|
KR20050045946A
(ko)
|
2002-06-25 |
2005-05-17 |
애크럭스 디디에스 피티와이 리미티드 |
비정질 약학적 조성물을 이용한 경피전달속도의 제어
|
US20050186141A1
(en)
*
|
2002-06-25 |
2005-08-25 |
Acrux Dds Pty Ltd. |
Transdermal aerosol compositions
|
US20050181032A1
(en)
*
|
2002-06-25 |
2005-08-18 |
Acrux Dds Pty Ltd. |
Metastable pharmaceutical compositions
|
DE10234673B4
(de)
|
2002-07-30 |
2007-08-16 |
Schwarz Pharma Ag |
Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
|
US8246980B2
(en)
*
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system
|
EP1386605A1
(de)
*
|
2002-07-30 |
2004-02-04 |
Schwarz Pharma Ag |
Verbessertes transdermales System für die Verabreichung von Rotigotin
|
US8246979B2
(en)
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system for the administration of rotigotine
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
WO2004037225A2
(en)
|
2002-10-25 |
2004-05-06 |
Foamix Ltd. |
Cosmetic and pharmaceutical foam
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
US8119150B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Non-flammable insecticide composition and uses thereof
|
US8486376B2
(en)
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
US8119109B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
US7192614B2
(en)
|
2002-11-05 |
2007-03-20 |
Gelstat Corporation |
Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
|
US20040086579A1
(en)
*
|
2002-11-05 |
2004-05-06 |
Higgins James W. |
Dietary supplement comprising parthenolide
|
US7374772B2
(en)
*
|
2002-11-07 |
2008-05-20 |
Bommarito Alexander A |
Topical antifungal treatment
|
US20040105818A1
(en)
|
2002-11-26 |
2004-06-03 |
Alexza Molecular Delivery Corporation |
Diuretic aerosols and methods of making and using them
|
ATE420647T1
(de)
|
2002-11-26 |
2009-01-15 |
Alexza Pharmaceuticals Inc |
Verwendung von loxapine für die herstellung eines mittels zur behandlung von schmerz
|
MXPA05005609A
(es)
*
|
2002-11-26 |
2005-07-26 |
Alexza Pharmaceuticals Inc |
Tratamiento de dolor de cabeza con antipsicoticos suministrados por inhalacion.
|
US7913688B2
(en)
|
2002-11-27 |
2011-03-29 |
Alexza Pharmaceuticals, Inc. |
Inhalation device for producing a drug aerosol
|
SI1426049T1
(en)
*
|
2002-12-02 |
2005-08-31 |
Sanol Arznei Schwarz Gmbh |
Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease
|
US20040220198A1
(en)
*
|
2002-12-20 |
2004-11-04 |
Kasturi Haldar |
Methods for treating malaria by modulation of G protein function
|
US9173836B2
(en)
|
2003-01-02 |
2015-11-03 |
FemmeParma Holding Company, Inc. |
Pharmaceutical preparations for treatments of diseases and disorders of the breast
|
MXPA05007266A
(es)
*
|
2003-01-02 |
2006-01-17 |
Femmepharma Holding Co Inc |
Preparaciones farmaceuticas para tratamientos de enfermedades y trastornos del seno.
|
US20040247707A1
(en)
*
|
2003-01-06 |
2004-12-09 |
Le Roy Charles Richard |
Pearl blue fast acting, long lasting topical pain relief cream
|
WO2004064841A1
(en)
*
|
2003-01-23 |
2004-08-05 |
Shire Holdings Ag |
Formulation and methods for the treatment of thrombocythemia
|
EP1444976A1
(de)
*
|
2003-02-10 |
2004-08-11 |
Novadel Pharma Inc. |
Bukkale, polare und nichtpolare Spray und Kapsel
|
ITFI20030070A1
(it)
*
|
2003-03-18 |
2004-09-19 |
Berlin Chemie Ag |
Formulazioni topiche stabilizzate contenenti ketoprofene
|
WO2004091521A2
(en)
*
|
2003-04-10 |
2004-10-28 |
Neurogesx, Inc. |
Methods and compositions for administration of trpv1 agonists
|
US7361376B2
(en)
*
|
2003-04-11 |
2008-04-22 |
International Flavors & Fragrances Inc. |
Alkyldienamides exhibiting taste and sensory effect in flavor compositions
|
US7632531B2
(en)
*
|
2003-04-11 |
2009-12-15 |
International Flavors & Fragnances Inc. |
Alkyldienamides exhibiting taste and sensory effect in flavor compositions
|
US7575739B2
(en)
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
US20040234914A1
(en)
|
2003-05-21 |
2004-11-25 |
Alexza Molecular Delivery Corporation |
Percussively ignited or electrically ingnited self-contained heating unit and drug-supply unit employing same
|
US20040247706A1
(en)
*
|
2003-06-06 |
2004-12-09 |
Roberts Stephen C. |
Transdermal dietary supplement comprising parthenolide
|
US20040247705A1
(en)
*
|
2003-06-06 |
2004-12-09 |
Roberts Stephen C. |
Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
|
US20040259852A1
(en)
*
|
2003-06-18 |
2004-12-23 |
White Hillary D. |
Trandsdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome
|
US8883769B2
(en)
*
|
2003-06-18 |
2014-11-11 |
White Mountain Pharma, Inc. |
Methods for the treatment of fibromyalgia and chronic fatigue syndrome
|
EP1488787A1
(de)
*
|
2003-06-20 |
2004-12-22 |
Berlin-Chemie Ag |
Topisch anzuwendende stabilisierte Arzneimittel enthaltend Ketoprofen
|
CA2433101A1
(en)
*
|
2003-06-23 |
2004-12-23 |
Igor Gonda |
Method of treatment of a female suffering from androgen insufficiency
|
US20050037040A1
(en)
*
|
2003-08-13 |
2005-02-17 |
Moshe Arkin |
Topical compositions of urea and ammonium lactate
|
US20050036953A1
(en)
*
|
2003-08-13 |
2005-02-17 |
Moshe Arkin |
Topical compositions of ammonium lactate
|
US20050042182A1
(en)
*
|
2003-08-13 |
2005-02-24 |
Moshe Arkin |
Topical compositions of urea
|
US6884906B2
(en)
*
|
2003-07-01 |
2005-04-26 |
International Flavors & Fragrances Inc. |
Menthyl half acid ester derivatives, processes for preparing same, and uses thereof for their cooling/refreshing effect in consumable materials
|
US7141686B2
(en)
|
2003-07-10 |
2006-11-28 |
International Flavors & Fragrances Inc. |
E2, E4, Z8-undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same
|
US20050025833A1
(en)
*
|
2003-07-16 |
2005-02-03 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
US20050042268A1
(en)
*
|
2003-07-16 |
2005-02-24 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
US20050020552A1
(en)
*
|
2003-07-16 |
2005-01-27 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
DE10334188B4
(de)
|
2003-07-26 |
2007-07-05 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung von Depressionen
|
US7323191B2
(en)
|
2003-07-28 |
2008-01-29 |
Alza Corporation |
Transdermal warfarin system
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
US8486374B2
(en)
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
WO2005016321A1
(en)
*
|
2003-08-15 |
2005-02-24 |
Qlt Usa, Inc. |
Adhesive bioerodible transmucosal drug delivery system
|
US20050043283A1
(en)
*
|
2003-08-22 |
2005-02-24 |
L'oreal S.A. |
Compositions containing topical active agents and pentylene glycol
|
US20060018852A1
(en)
*
|
2003-08-22 |
2006-01-26 |
L'oreal |
Compositions containing topical active agents and pentylene glycol
|
US20060263350A1
(en)
*
|
2003-09-26 |
2006-11-23 |
Fairfield Clinical Trials Llc |
Combination antihistamine medication
|
US8007839B2
(en)
*
|
2003-10-03 |
2011-08-30 |
International Flavors & Fragrances |
Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
|
US7329767B2
(en)
*
|
2003-10-03 |
2008-02-12 |
International Flavors & Fragrances Inc. |
Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
|
US7387788B1
(en)
|
2003-10-10 |
2008-06-17 |
Antares Pharma Ipl Ag |
Pharmaceutical compositions of nicotine and methods of use thereof
|
ATE534373T1
(de)
|
2003-10-10 |
2011-12-15 |
Antares Pharma Ipl Ag |
Transdermale pharmazeutische formulierung zur minimierung von rückständen auf der haut
|
KR100552650B1
(ko)
*
|
2003-11-17 |
2006-02-20 |
아이큐어 주식회사 |
피록시캄 함유 소염진통용 플라스터
|
US20050129756A1
(en)
*
|
2003-12-10 |
2005-06-16 |
Hans-Peter Podhaisky |
UV-stable, liquid or semisolid transdermal pharmaceutical preparation with light sensitive active ingredient
|
CA2548596A1
(en)
*
|
2003-12-10 |
2005-06-23 |
Acrux Dds Pty Ltd. |
Method of treatment for undesired effect following transdermal or topical drug delivery
|
EP1541136A1
(de)
*
|
2003-12-10 |
2005-06-15 |
Schering AG |
UV-Licht stabile halbfeste transdermale Systeme, die einen lichtempfindlichen Wirkstoff und einen UV-Absorber enthalten
|
EP1547592A1
(de)
|
2003-12-23 |
2005-06-29 |
Schwarz Pharma Ag |
Intranasale formulierung enthaltend
|
DE10361258A1
(de)
|
2003-12-24 |
2005-07-28 |
Schwarz Pharma Ag |
Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
|
DE102004014841B4
(de)
|
2004-03-24 |
2006-07-06 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
US8741332B2
(en)
|
2004-06-07 |
2014-06-03 |
Nuvo Research Inc. |
Compositions and methods for dermally treating neuropathic pain
|
US8741333B2
(en)
|
2004-06-07 |
2014-06-03 |
Nuvo Research Inc. |
Compositions and methods for treating dermatitis or psoriasis
|
US8907153B2
(en)
*
|
2004-06-07 |
2014-12-09 |
Nuvo Research Inc. |
Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
|
US20060002989A1
(en)
*
|
2004-06-10 |
2006-01-05 |
Ahmed Salah U |
Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
|
US20060030574A1
(en)
*
|
2004-08-04 |
2006-02-09 |
Shire Holdings Ag |
Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
|
US7700608B2
(en)
*
|
2004-08-04 |
2010-04-20 |
Shire Holdings Ag |
Quinazoline derivatives and their use in the treatment of thrombocythemia
|
EP1784150A4
(de)
*
|
2004-09-01 |
2011-05-11 |
Nexmed Holdings Inc |
Transdermales antiemese-abgabesystem, verfahren und zusammensetzung dafür
|
US7541055B2
(en)
*
|
2004-09-10 |
2009-06-02 |
International Flavors & Fragrances Inc. |
Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions
|
US7427421B2
(en)
*
|
2004-09-10 |
2008-09-23 |
International Flavors & Fragrances Inc. |
Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions
|
US8252319B2
(en)
|
2004-10-21 |
2012-08-28 |
Durect Corporation |
Transdermal delivery system for sufentanil
|
NZ582975A
(en)
|
2004-10-21 |
2011-07-29 |
Durect Corp |
Transdermal delivery systems delivering sufentanil
|
US7001592B1
(en)
*
|
2005-01-31 |
2006-02-21 |
Aquea Scientific Corporation |
Sunscreen compositions and methods of use
|
WO2006084312A1
(en)
*
|
2005-02-09 |
2006-08-17 |
Acrux Dds Pty Ltd |
Method of promoting hair growth
|
BRPI0607461A2
(pt)
*
|
2005-02-14 |
2009-09-08 |
Neurogesx Inc |
dispositivo para liberação de agonistas de trpv1
|
EP1848270B1
(de)
|
2005-02-17 |
2014-05-21 |
Abbott Laboratories |
Transmukosale verabreichung von arzneimittelzusammensetzungen zur behandlung und vorbeugung von erkrankungen bei tieren
|
US20080112904A1
(en)
*
|
2005-03-08 |
2008-05-15 |
Daniel Henry Traynor |
Sunscreen Compositions And Methods Of Use
|
EP2601964B1
(de)
|
2005-03-21 |
2018-07-25 |
The Trustees of Columbia University in the City of New York |
Balanol-verbindungen zur Anwendung bei der Behandlung von Schmerz
|
AU2006227561B2
(en)
*
|
2005-03-24 |
2011-06-09 |
Ensign Laboratories Pty Ltd |
Sunscreen aerosol spray
|
US20090061001A1
(en)
*
|
2005-03-24 |
2009-03-05 |
Ensign Laboratories Pty Ltd |
Sunscreen aerosol spray
|
EP1865933B1
(de)
*
|
2005-03-30 |
2015-11-04 |
Vanderbilt Royalty Sub L.P. |
Capsaicin-pflaster mit geringer konzentration und verfahren zur behandlung von neuropathischem schmerz
|
US20060222692A1
(en)
*
|
2005-03-31 |
2006-10-05 |
Fairfield Clinical Trials Llc |
Method and compositions for transdermal administration of antimicrobial medications
|
WO2007124250A2
(en)
|
2006-04-21 |
2007-11-01 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
ES2785999T3
(es)
*
|
2005-05-16 |
2020-10-08 |
Novapharm Res Australia Pty Limited |
Composición para su uso en la preparación de un paciente para cirugía
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
EP1896038B1
(de)
|
2005-06-03 |
2016-11-09 |
Acrux DDS Pty Ltd |
Verfahren und zusammensetzung für die transdermale abgabe von testosteron
|
CN101212975A
(zh)
|
2005-06-03 |
2008-07-02 |
艾克若克斯Dds有限公司 |
用于透皮给药的方法和组合物
|
JP4696701B2
(ja)
|
2005-06-07 |
2011-06-08 |
ソニー株式会社 |
抵抗回路
|
CA2578626C
(en)
*
|
2005-06-27 |
2011-07-19 |
Biovail Laboratories International S.R.L. |
Modified-release formulations of a bupropion salt
|
KR100699582B1
(ko)
|
2005-07-11 |
2007-03-23 |
삼성전기주식회사 |
출력 버퍼회로
|
CN103784960A
(zh)
*
|
2005-07-27 |
2014-05-14 |
阿尔卡米亚肿瘤学股份有限公司 |
使用乙酰透明质酸的治疗方案
|
CA2615710C
(en)
*
|
2005-07-28 |
2017-09-12 |
Color Foundation (Stichting Color) |
Sensitization of immune system against haptenized melanoma antigens
|
AU2006289651B2
(en)
*
|
2005-09-07 |
2012-07-26 |
Alchemia Oncology Pty Limited |
Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
|
AU2006299833B2
(en)
|
2005-10-12 |
2012-04-12 |
Besins Healthcare Luxembourg Sarl |
Improved testosterone gel and method of use
|
US20070087055A1
(en)
*
|
2005-10-14 |
2007-04-19 |
David Jan |
Directly compressible extended release alprazolam formulation
|
DE112006002834T5
(de)
|
2005-11-04 |
2008-10-30 |
Acrux DDS Pty. Ltd., West Melbourne |
Verfahren und System für eine transdermale Arzneimittelzufuhr
|
JP2009516687A
(ja)
*
|
2005-11-21 |
2009-04-23 |
シェーリング−プラウ・リミテッド |
ブプレノルフィンを含む薬学的組成物
|
EP1962795A1
(de)
*
|
2005-12-07 |
2008-09-03 |
PharmaKodex Ltd |
Topische zusammensetzungen zur anwendung bei kindern
|
GB0524958D0
(en)
*
|
2005-12-07 |
2006-01-18 |
Pharmakodex Ltd |
Transdermal administration of active agents
|
GB0524962D0
(en)
*
|
2005-12-07 |
2006-01-18 |
Pharmakodex Ltd |
Topical pharmaceutical compositions
|
GB0524961D0
(en)
*
|
2005-12-07 |
2006-01-18 |
Pharmakodex Ltd |
Transdermal administration of active agents for systemic effect
|
AU2006326388B2
(en)
*
|
2005-12-14 |
2013-01-24 |
Nuvo Research Inc. |
Compositions and methods for treating dermatological conditions
|
JP2009524586A
(ja)
*
|
2005-12-14 |
2009-07-02 |
ザーズ, インコーポレイテッド |
疼痛を皮膚処置するための組成物および方法
|
US9017717B2
(en)
*
|
2006-01-16 |
2015-04-28 |
Peach Technologies Llc |
Bandage for facilitating transdermal respiration and healing
|
US7985770B2
(en)
|
2006-01-24 |
2011-07-26 |
Sucampo Ag |
Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
|
WO2007095586A2
(en)
|
2006-02-14 |
2007-08-23 |
The Trustees Of Columbia University In The City Of New York |
Neuronal pain pathway modulators
|
DE102006010329A1
(de)
*
|
2006-03-06 |
2007-09-13 |
Höltge, Michael, Dipl.-Med. |
Hormonelles Kontrazeptivum auf der Basis eines Estrogens, eines Gestagens oder einer Kombination von Estrogenen und Gestagenen unter der Zugabe von Testosteron
|
WO2007117581A2
(en)
*
|
2006-04-06 |
2007-10-18 |
Collegium Pharmaceutical, Inc. |
Stabilized transdermal bupropion preparations
|
CA2649895C
(en)
*
|
2006-04-19 |
2013-03-26 |
Novadel Pharma Inc. |
Stable hydroalcoholic oral spray formulations and methods
|
US9468600B2
(en)
|
2006-05-26 |
2016-10-18 |
Dr. Holmquist Healthcare, LLC |
Compositions for the transdermal delivery of physiologically active agents
|
TW200815045A
(en)
*
|
2006-06-29 |
2008-04-01 |
Jazz Pharmaceuticals Inc |
Pharmaceutical compositions of ropinirole and methods of use thereof
|
US20080090850A1
(en)
*
|
2006-10-13 |
2008-04-17 |
Anderson Mark E |
Herpetic neuralgia topical treatment
|
DE102006050558B4
(de)
|
2006-10-26 |
2009-03-26 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System enthaltend Norelgestromin zur Kontrazeption und Hormonsubstitution
|
US20080260655A1
(en)
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
US8304420B2
(en)
|
2006-11-28 |
2012-11-06 |
Shire Llc |
Substituted quinazolines for reducing platelet count
|
US7910597B2
(en)
*
|
2006-11-28 |
2011-03-22 |
Shire Llc |
Substituted quinazolines
|
EP2124897A4
(de)
*
|
2006-12-22 |
2012-05-09 |
Novadel Pharma Inc |
Stabile orale spray-formulierungen und verfahren gegen übelkeit
|
DK2104659T3
(en)
*
|
2007-01-08 |
2015-11-02 |
Allianz Pharmascience Ltd |
Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof
|
EP2106272A4
(de)
*
|
2007-01-11 |
2011-05-04 |
Acrux Dds Pty Ltd |
Spreizutensil
|
JP5319121B2
(ja)
|
2007-01-30 |
2013-10-16 |
株式会社東芝 |
診療支援システム及び診療支援装置
|
US20080216828A1
(en)
|
2007-03-09 |
2008-09-11 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
US8940326B2
(en)
|
2007-03-19 |
2015-01-27 |
Vita Sciences Llc |
Transdermal patch and method for delivery of vitamin B12
|
WO2008128280A1
(en)
*
|
2007-04-20 |
2008-10-30 |
Acrux Dds Pty Ltd |
Method and system for transdermal administration of volatile active
|
WO2008141264A1
(en)
*
|
2007-05-10 |
2008-11-20 |
Novadel Pharma Inc. |
Anti-insomnia compositions and methods
|
BRPI0811778A2
(pt)
*
|
2007-05-21 |
2014-09-30 |
Aquea Scient Corp |
Microcápsulas altamente carregadas
|
DE102007032468A1
(de)
|
2007-07-10 |
2009-01-15 |
Brätter, Christian, Dr. |
Transdermale Therapeutische Systeme, welche den Wirkstoff Anastrozol enthalten
|
HU227970B1
(en)
*
|
2007-07-10 |
2012-07-30 |
Egis Gyogyszergyar Nyrt |
Pharmaceutical compositions containing silicones of high volatility
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
AR068408A1
(es)
*
|
2007-09-14 |
2009-11-18 |
Drugtech Corp |
Pulverizacion de hormonas transdermicas
|
AR068409A1
(es)
*
|
2007-09-14 |
2009-11-18 |
Drugtech Corp |
Composiciones farmaceuticas, transdermicas sin alcohol
|
PT2219603E
(pt)
*
|
2007-11-02 |
2014-09-02 |
Acrux Dds Pty Ltd |
Piperazinas como agentes antimalariais
|
WO2009069006A2
(en)
|
2007-11-30 |
2009-06-04 |
Foamix Ltd. |
Foam containing benzoyl peroxide
|
WO2009072007A2
(en)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
WO2010041141A2
(en)
|
2008-10-07 |
2010-04-15 |
Foamix Ltd. |
Oil-based foamable carriers and formulations
|
EP2242476A2
(de)
|
2008-01-14 |
2010-10-27 |
Foamix Ltd. |
Aufschäumbare pharmazeutische poloxamer-zusammensetzungen mit wirkstoffen und/oder therapeutischen zellen und verwendungen
|
US20110052738A1
(en)
*
|
2008-01-17 |
2011-03-03 |
Gary Dean Bennett |
Topical pain formulation
|
US8123082B2
(en)
*
|
2008-01-22 |
2012-02-28 |
McNeil-AB |
Hand-held dispensing device
|
KR20110007088A
(ko)
*
|
2008-01-25 |
2011-01-21 |
비 앤드 티 에스.알.엘. |
화장품 분야에서의 트랜스에스테르화 올리브 오일의 용도
|
JP4879928B2
(ja)
*
|
2008-03-25 |
2012-02-22 |
帝國製薬株式会社 |
ケトプロフェンリジン塩を含有する水性貼付剤
|
US20090259176A1
(en)
*
|
2008-04-09 |
2009-10-15 |
Los Gatos Research, Inc. |
Transdermal patch system
|
EP2309993A1
(de)
|
2008-06-25 |
2011-04-20 |
US Worldmeds LLC |
Hautpflaster und lofexidin enthaltende formulierungen mit verzögerter freisetzung zur transdermalen und oralen verabreichung
|
US20100048598A1
(en)
*
|
2008-08-21 |
2010-02-25 |
Sateesh Kandavilli |
Topical compositions comprising 5-alpha reductase inhibitors
|
EP2334234A4
(de)
|
2008-09-19 |
2013-03-20 |
Tandem Diabetes Care Inc |
Vorrichtung zur messung der konzentration eines gelösten stoffs und entsprechende verfahren
|
US8748177B2
(en)
*
|
2008-09-30 |
2014-06-10 |
The Hospital For Sick Children |
Compositions for proliferation of cells and related methods
|
ES2400210T3
(es)
|
2008-10-02 |
2013-04-08 |
Mylan Inc. |
Método para preparar un laminado de adhesivo multicapa
|
CN102307895A
(zh)
*
|
2008-12-04 |
2012-01-04 |
里兰斯坦福初级大学理事会 |
用于治疗或预防麻醉药停药症状的方法和组合物
|
US8573027B2
(en)
|
2009-02-27 |
2013-11-05 |
Tandem Diabetes Care, Inc. |
Methods and devices for determination of flow reservoir volume
|
US9250106B2
(en)
|
2009-02-27 |
2016-02-02 |
Tandem Diabetes Care, Inc. |
Methods and devices for determination of flow reservoir volume
|
WO2010125470A2
(en)
|
2009-04-28 |
2010-11-04 |
Foamix Ltd. |
Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
|
US20100298397A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Singh Nikhilesh N |
Method of treatment of obsessive compulsive disorder with ondansetron
|
US9517023B2
(en)
|
2009-06-01 |
2016-12-13 |
Profusa, Inc. |
Method and system for directing a localized biological response to an implant
|
CA2769677A1
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
CA2769625C
(en)
|
2009-07-29 |
2017-04-11 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
CA2921304C
(en)
|
2009-07-30 |
2018-06-05 |
Tandem Diabetes Care, Inc. |
Infusion pump system with disposable cartridge having pressure venting and pressure feedback
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
WO2011039638A2
(en)
|
2009-10-02 |
2011-04-07 |
Foamix Ltd. |
Topical tetracycline compositions
|
WO2011044540A1
(en)
|
2009-10-09 |
2011-04-14 |
Nuvo Research Inc. |
Topical formulation comprising etoricoxib and a zwitterionic surfactant
|
US8894630B2
(en)
|
2009-11-13 |
2014-11-25 |
The Invention Science Fund I, Llc |
Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
|
US8439896B2
(en)
*
|
2009-11-13 |
2013-05-14 |
The Invention Science Fund I, Llc |
Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
|
US9078863B2
(en)
*
|
2009-11-13 |
2015-07-14 |
The Invention Science Fund I, Llc |
Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
|
CN107115326B
(zh)
|
2010-04-13 |
2021-01-22 |
雷尔玛达治疗股份有限公司 |
1-甲基-n-(2,6-二甲苯基)-2-哌啶甲酰胺的皮肤用药物组合物及其使用方法
|
SG186299A1
(en)
*
|
2010-05-04 |
2013-01-30 |
Nexmed Holdings Inc |
Compositions of small molecule therapeutics
|
US10010272B2
(en)
|
2010-05-27 |
2018-07-03 |
Profusa, Inc. |
Tissue-integrating electronic apparatus
|
US20120022033A1
(en)
*
|
2010-07-23 |
2012-01-26 |
Biosante Pharmaceuticals, Inc. |
Methods for decreasing cardiovascular risk in postmenopausal women
|
JP2013538231A
(ja)
|
2010-09-17 |
2013-10-10 |
ブラッシカ プロテクション プロダクツ リミテッド ライアビリティ カンパニー |
グルコシノレートによる処置のための製剤
|
CN103260501B
(zh)
|
2010-10-06 |
2015-09-02 |
普罗弗萨股份有限公司 |
组织整合性传感器
|
WO2012048455A1
(zh)
*
|
2010-10-12 |
2012-04-19 |
武汉大学 |
一种抗病毒透皮吸收贴片及其制备方法
|
SE535588C2
(sv)
*
|
2010-10-29 |
2012-10-02 |
Redsense Medical Ab |
Detektion av blodläckage genom påvisning av förekomsten av flyktiga ämnen
|
EP2640398A4
(de)
|
2010-11-18 |
2014-05-14 |
White Mountain Pharma Inc |
Verfahren zur behandlung chronischer bzw. nicht linderbarer schmerzen und/oder erhöhung der schmerzschwelle bei einem patienten und pharmazeutische zusammensetzung zur verwendung darin
|
JP2014505726A
(ja)
|
2011-02-15 |
2014-03-06 |
イーライ リリー アンド カンパニー |
フェンタニルの経皮溶液を使用してイヌにおける疼痛を抑制するための方法
|
EA022648B1
(ru)
|
2011-02-15 |
2016-02-29 |
Эли Лилли Энд Компани |
Способы контролирования боли у животных семейства лошадиных с применением трансдермального раствора фентанила
|
US9119793B1
(en)
|
2011-06-28 |
2015-09-01 |
Medicis Pharmaceutical Corporation |
Gastroretentive dosage forms for doxycycline
|
PT2747693T
(pt)
*
|
2011-08-26 |
2018-07-03 |
On Light Sciences Inc |
Sistema e método para a remoção de tatuagens
|
PT2782584T
(pt)
|
2011-11-23 |
2021-09-02 |
Therapeuticsmd Inc |
Preparações e terapias de substituição para hormonoterapias naturais combinadas
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
CN103181956B
(zh)
*
|
2011-12-30 |
2015-04-29 |
天津市山佳医药科技有限公司 |
一种治疗退行性骨关节痛的透皮吸收贴剂
|
US9180242B2
(en)
|
2012-05-17 |
2015-11-10 |
Tandem Diabetes Care, Inc. |
Methods and devices for multiple fluid transfer
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10045965B2
(en)
|
2012-07-31 |
2018-08-14 |
Egis Pharmaceuticals Plc |
Transdermal formulation containing COX inhibitors
|
US11154535B2
(en)
|
2012-07-31 |
2021-10-26 |
Egis Pharmaceuticals Plc |
Transdermal formulation containing COX inhibitors
|
US10045935B2
(en)
|
2012-07-31 |
2018-08-14 |
Egis Pharmaceuticals Plc |
Transdermal formulation containing COX inhibitors
|
ES2813340T3
(es)
|
2012-09-21 |
2021-03-23 |
Intensity Therapeutics Inc |
Método de tratamiento del cáncer
|
EP2908853B1
(de)
|
2012-10-21 |
2018-12-05 |
University Of Rochester |
Thy1 (cd90) als therapie zur steuerung von fettgewebeakkumulation
|
US10322301B2
(en)
|
2012-11-06 |
2019-06-18 |
CoLabs International Corporation |
Compositions containing a cellulose derived capsule with a sunscreen active agent
|
US11707421B2
(en)
|
2012-11-06 |
2023-07-25 |
Colabs Int'l Corp. |
Compositions containing a flexible derived capsule with an active agent
|
US11690793B2
(en)
|
2012-11-06 |
2023-07-04 |
Colabs Int'l Corp. |
Composition containing a cellulose derived capsule with a sunscreen
|
US11724134B2
(en)
|
2012-11-06 |
2023-08-15 |
CoLabs International Corporation |
Compositions containing a cellulose derived capsule with a sunscreen active agent
|
US11491088B2
(en)
|
2012-11-06 |
2022-11-08 |
CoLabs International Corporation |
Compositions containing a capsule with a moisturizing agent
|
US9456966B2
(en)
|
2012-11-06 |
2016-10-04 |
CoLabs International Corporation |
Composition containing a cellulose derived capsule with a sunscreen
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
CA2939259C
(en)
|
2013-02-11 |
2021-01-26 |
Glycanova As |
Basidiomycete-derived cream for treatment of skin diseases
|
US9173998B2
(en)
|
2013-03-14 |
2015-11-03 |
Tandem Diabetes Care, Inc. |
System and method for detecting occlusions in an infusion pump
|
CN108013881B
(zh)
|
2013-03-14 |
2021-06-15 |
普罗菲尤萨股份有限公司 |
用于校正光学信号的方法和装置
|
US10842802B2
(en)
|
2013-03-15 |
2020-11-24 |
Medicis Pharmaceutical Corporation |
Controlled release pharmaceutical dosage forms
|
EP3777656A1
(de)
|
2013-06-06 |
2021-02-17 |
Profusa, Inc. |
Vorrichtung und verfahren zur detektion optischer signale aus implantierten sensoren
|
USD750788S1
(en)
|
2013-11-26 |
2016-03-01 |
Acrux Dds Pty Ltd |
Topical spreading applicator
|
USD749225S1
(en)
|
2013-11-26 |
2016-02-09 |
Acrux Dds Pty Ltd |
Topical spreading applicator
|
USD752287S1
(en)
|
2013-12-09 |
2016-03-22 |
Amneal Pharmaceuticals Llc |
Applicator for applying a liquid to a surface
|
US9227044B2
(en)
|
2013-12-09 |
2016-01-05 |
Amneal Pharmaceuticals Llc |
Applicator for applying a fluid to a surface
|
WO2015100118A1
(en)
*
|
2013-12-24 |
2015-07-02 |
The Procter & Gamble Company |
Cosmetic compositions and methods providing enhanced penetration of skin care actives
|
US9561233B2
(en)
|
2014-03-13 |
2017-02-07 |
Demerx, Inc. |
Use of ibogaine for the treatment of pain
|
KR102364378B1
(ko)
|
2014-05-21 |
2022-02-16 |
에스케이케미칼 주식회사 |
안정성을 향상시킨 로티고틴 함유 경피흡수제제
|
AR100562A1
(es)
|
2014-05-22 |
2016-10-12 |
Therapeuticsmd Inc |
Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
|
US11696883B2
(en)
|
2014-05-23 |
2023-07-11 |
Triple Hair Inc. |
Compositions for reducing hair loss and/or increasing hair regrowth
|
CN105658223B
(zh)
|
2014-05-23 |
2018-12-04 |
特里普海尔公司 |
用于减少脱发和/或增加毛发再生的组合物
|
US20160022643A1
(en)
*
|
2014-07-22 |
2016-01-28 |
Professional Compounding Centers Of America |
Oral Transmucosal Compositions including Aromatase Inhibitors for Low Testosterone Levels in Men
|
US9592239B2
(en)
|
2014-09-12 |
2017-03-14 |
Demerx, Inc. |
Methods and compositions for ibogaine treatment of impulse control disorder, anxiety-related disorders, violence and/or anger, or regulating food intake
|
WO2016123406A1
(en)
|
2015-01-28 |
2016-08-04 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
CN107708665B
(zh)
|
2015-03-23 |
2022-07-22 |
贝尔生物制药有限公司 |
用于皮肤病学用途的药用四环素组合物
|
US20160307158A1
(en)
*
|
2015-04-16 |
2016-10-20 |
Linkedin Corporation |
Aggregating and transforming user actions into social signal features for a job recommendation engine
|
PT3347009T
(pt)
|
2015-07-08 |
2022-01-12 |
Triple Hair Inc |
Composição compreendendo resveratrol e melatonina para reduzir a perda de cabelo e/ou aumentar o crescimento do cabelo
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
WO2017173044A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
CA3020153A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
US10549129B2
(en)
|
2016-06-24 |
2020-02-04 |
The Procter & Gamble Company |
Cosmetic compositions and methods providing enhanced penetration of skin care actives
|
MX2020012139A
(es)
|
2016-09-08 |
2021-01-29 |
Vyne Pharmaceuticals Inc |
Composiciones y metodos para tratar rosacea y acne.
|
KR102499141B1
(ko)
|
2016-10-31 |
2023-02-13 |
신신제약 주식회사 |
수면장애 치료용 경피흡수제제
|
WO2018118197A1
(en)
*
|
2016-12-21 |
2018-06-28 |
Richard Postrel |
Healthier aging in domesticated animals
|
US11331018B2
(en)
|
2016-12-22 |
2022-05-17 |
Profusa, Inc. |
System and single-channel biosensor for and method of determining analyte value
|
EP3565617A1
(de)
|
2017-01-06 |
2019-11-13 |
Chrono Therapeutics Inc. |
Vorrichtungen und verfahren zur transdermalen wirkstofffreisetzung
|
US10396053B2
(en)
*
|
2017-11-17 |
2019-08-27 |
General Electric Company |
Semiconductor logic device and system and method of embedded packaging of same
|
AU2019206552B2
(en)
*
|
2018-01-10 |
2023-02-09 |
Celista Pharmaceuticals Llc |
Testosterone transdermal spray with film
|
CA3101966A1
(en)
|
2018-05-29 |
2019-12-05 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
EP3813786A4
(de)
|
2018-06-27 |
2022-06-29 |
Colabs International Corporation |
Zusammensetzungen mit siliziumdioxidbasierten partikeln, die ein oder mehrere mittel enthalten
|
CA3119992A1
(en)
*
|
2018-11-16 |
2020-05-22 |
Morningside Venture Investments Limited |
Thermally regulated transdermal drug delivery system
|
WO2020243538A1
(en)
*
|
2019-05-31 |
2020-12-03 |
Primo Pharmatech Llc |
Unit dosage form for transmucosal drug delivery of an active pharmaceutical ingredient
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
KR102503159B1
(ko)
|
2020-04-29 |
2023-02-23 |
신신제약 주식회사 |
멜라토닌을 함유하는 경피흡수제제
|